Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.
Cortes, Jorge E
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. [electronic resource] - Leukemia 02 2019 - 379-389 p. digital
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1476-5551
10.1038/s41375-018-0312-9 doi
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--administration & dosage
Benzimidazoles--administration & dosage
Cytarabine--administration & dosage
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Leukemia, Myeloid, Acute--diagnosis
Male
Middle Aged
Myelodysplastic Syndromes--diagnosis
Phenylurea Compounds--administration & dosage
Prognosis
Survival Rate
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. [electronic resource] - Leukemia 02 2019 - 379-389 p. digital
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1476-5551
10.1038/s41375-018-0312-9 doi
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--administration & dosage
Benzimidazoles--administration & dosage
Cytarabine--administration & dosage
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Leukemia, Myeloid, Acute--diagnosis
Male
Middle Aged
Myelodysplastic Syndromes--diagnosis
Phenylurea Compounds--administration & dosage
Prognosis
Survival Rate